sofidexFor patientsAre you a clinician? Clinical site

Health Library  ›  News  ›  Health notices · Wednesday 19 August

Updates ·

Health notices · Wednesday 19 August

3 notices from the agencies today, in plain words, each with the original linked.

About 1 minute to readNoticePublished August 2026

PDF
a plain paper envelope and an unopened cardboard box on a table

Prolon Apulian Almond & Cocoa Spread recalled over undeclared tree nuts

Centers for Disease Control and Prevention (CDC) · Food safety

If you have an allergy or severe sensitivity to cashew, pistachio, and/or hazelnut, this recall may affect you. The product was recalled because it contains undeclared tree nuts (cashew, pistachio, and hazelnut).

Using or having the recalled spread could put you at risk of a serious or life-threatening allergic reaction.

What to do

  • Check whether you have Prolon brand Apulian Almond & Cocoa Spread and follow the recall guidance provided by the company.

Read the original notice

Cyclophosphamide injection linked to particulate contamination

FDA · Recall

If you are given cyclophosphamide injection (an anticancer medicine), the Food and Drug Administration (FDA) says some vials were found to contain particulate matter identified as stainless steel.

The affected product is cyclophosphamide for injection, USP, 1 gram/vial (one single-dose vial), supplied under the listed NDC and distributed across the USA.

The FDA’s notice does not include specific instructions for patients in the information provided here.

Read the original notice

FDA approves gabapentin enacarbil (Horizant) for restless legs and nerve pain

FDA · Approval

If you are an adult with moderate-to-severe primary Restless Legs Syndrome (RLS), the FDA has approved Horizant to treat it.

If you are an adult with postherpetic neuralgia (PHN), a nerve pain that can follow shingles, the FDA has approved Horizant to manage it.

Read the original notice